MedWatch

GN executive: ”We fear neither Trump nor Brexit”

A forthcoming Brexit, extra taxes on medical devices, OTC markets, and an unruly Donald Trump – it all creates political and regulatory uncertainty. However, it does not discourage CEO in GN Hearing, Anders Hedegaard. “We are well placed to deliver,” he says.

Foto: GN Resound, PR

“GN Hearing is in very good form, at home as well as in the rest of the world. We have challenges but we are well placed to grow further and gain more market shares.”

This is the immediate comment from Anders Hedegaard, CEO in GN Hearing, when MedWatch interviews him shortly after the presentation of the annual report 2017. In the last quarter, the company strained every nerve to deliver its guidance for the year and succeeded.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Sydbank-analytiker: Positivt at Bavarian Nordic-aktiesalg klares hurtigt

Det er positivt, vurderer analytiker i Sydbank, at Bavarian Nordic allerede om en uge regner med at kunne præsentere resultatet af det udbud, selskabet tidligere mandag offentliggjorde, som skal sikre finansiering af et fase 3-studie med en vaccinekandidat mod RS-virus i første halvår 2022.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier